Thanks for reminding us.--over the past 5 years, bluebird stock has declined in value by 95%.
Hey on KRTX, here's the other thing, the open interest on all the calls that are way out of the money, is basically nil. For each expiration out to Feb of '23. With all those fat premiums, you'd think these funds would be selling the calls, but they're not. That's a pretty bullish sign imo. They have research scientists working for them who know about a million times more than you and I about these things.
My guess is this thing gets approved.
But who knows. The FDA can be funny...
edit:
Ya know, if you remember, that's what tipped me off (Us off
) on ROBLX when it was $70 BEFORE it went north of $100. The $90 calls were like $5 and no one was selling any.
Last edited: